ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
US Tech 100
20,762.73
1.73%
Dow Jones
42,732.13
0.80%
Brent Oil
76.505
0.01%
Bitcoin
98,396.00
0.19%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Neurones Sa (0GX2) Quote

Neurones Sa

Neurones Sa (0GX2)

LSE
25.90
0.00
(0.00%)
Closed January 05 11:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
25.90
Bid
0.00
Ask
0.00
Volume
47
0.00 Day's Range 0.00
25.90 52 Week Range 25.90
Market Cap
628.826M
Previous Close
25.90
Open
-
Last Trade
47
@
44.5
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
116
Shares Outstanding
24,279,000
Dividend Yield
-
PE Ratio
21.92
Earnings Per Share (EPS)
2.04
Revenue
743.71M
Net Profit
49.41M

About Neurones Sa

Sector
Computer Programming Service
Industry
Computer Programming Service
Website
www.neurones.net
Headquarters
Nanterre, Hauts-de-seine, Fra
Founded
-
Neurones Sa is listed in the Computer Programming Service sector of the London Stock Exchange with ticker 0GX2. The last closing price for Neurones was 25.90 €. Over the last year, Neurones shares have traded in a share price range of 25.90 € to 25.90 €.

Neurones currently has 24,279,000 shares outstanding. The market capitalization of Neurones is 628.83 € million. Neurones has a price to earnings ratio (PE ratio) of 21.92.

Ask ADVFN Intelligence (AI)

0GX2 Latest News

More News

NEURONES : + 10,5% de croissance organique au 3e trimestre 2024

NEURONES : + 10,5% de croissance organique au 3e trimestre 2024 INFORMATION PRESSERubrique : C.A. 3e trimestre 2024        Nanterre, le 6 novembre 2024 (après Bourse) + 10,5% de croissance...

November 06 2024
UK Regulatory

Neurones: Organic growth up 10.5% in 3rd quarter 2024

Neurones: Organic growth up 10.5% in 3rd quarter 2024 PRESS INFORMATIONHeading: 3rd quarter 2024 revenues        Nanterre, November 6, 2024 (after trading) Organic growth up 10.5% in 3rd quarter...

November 06 2024
UK Regulatory

NEURONES - Rapport financier premier semestre 2024

NEURONES - Rapport financier premier semestre 2024 NEURONES-rapport-financier-premier-semestre-2024 Pièce jointe NEURONES-rapport-financier-premier-semestre-2024

September 13 2024
UK Regulatory

NEURONES : 7,3% de résultat net au 1er semestre 2024

NEURONES : 7,3% de résultat net au 1er semestre 2024 INFORMATION PRESSERubrique : Résultats 1er semestre 2024        Nanterre, le 11 septembre 2024 (après Bourse) 7,3% de résultat net au 1er...

September 11 2024
UK Regulatory

Neurones: 7.3% net profit in 1st half 2024

Neurones: 7.3% net profit in 1st half 2024 PRESS INFORMATIONHeading: 1st half 2024 results        Nanterre, September 11, 2024 (after trading) 7.3% net profit in 1st half 2024 (in millions of...

September 11 2024
UK Regulatory

NEURONES: Growth up 9.1% in 1st half 2024

NEURONES: Growth up 9.1% in 1st half 2024 PRESS INFORMATION        Nanterre, August 7, 2024 (after trading)Heading: 1st half 2024 revenues Growth up 9.1% in 1st half 2024 in millions of eurosH1...

August 07 2024
UK Regulatory

NEURONES : + 9,1% de croissance au 1er semestre 2024

NEURONES : + 9,1% de croissance au 1er semestre 2024 INFORMATION PRESSE        Nanterre, le 7 août 2024 (après Bourse)Rubrique : C.A. 1er semestre 2024 + 9,1% de croissance au 1er semestre 2024...

August 07 2024
UK Regulatory

NEURONES : Descriptif du programme de rachat d'actions

NEURONES : Descriptif du programme de rachat d'actions INFORMATION PRESSERubrique : Rachat d’actions        Nanterre, le vendredi 7 juin 2024 (après Bourse) DESCRIPTIF DU PROGRAMME DE...

June 07 2024
GlobeNewswire Inc.

NEURONES : + 8,6% de croissance organique au 1er trimestre 2024

NEURONES : + 8,6% de croissance organique au 1er trimestre 2024 INFORMATION PRESSERubrique : C.A. 1er trimestre 2024        Nanterre, le 15 mai 2024 (après Bourse) + 8,6% de croissance...

May 15 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10025.925.925.93425.9DE
40025.925.925.98925.9DE
120025.925.925.911625.9DE
260025.925.925.98125.9DE
520025.925.925.930625.9DE
1560025.925.925.922425.9DE
2600025.925.925.933725.9DE

0GX2 - Frequently Asked Questions (FAQ)

What is the current Neurones share price?
The current share price of Neurones is 25.90 €
How many Neurones shares are in issue?
Neurones has 24,279,000 shares in issue
What is the market cap of Neurones?
The market capitalisation of Neurones is EUR 628.83M
What is the 1 year trading range for Neurones share price?
Neurones has traded in the range of 25.90 € to 25.90 € during the past year
What is the PE ratio of Neurones?
The price to earnings ratio of Neurones is 21.92
What is the cash to sales ratio of Neurones?
The cash to sales ratio of Neurones is 1.46
What is the reporting currency for Neurones?
Neurones reports financial results in EUR
What is the latest annual turnover for Neurones?
The latest annual turnover of Neurones is EUR 743.71M
What is the latest annual profit for Neurones?
The latest annual profit of Neurones is EUR 49.41M
What is the registered address of Neurones?
The registered address for Neurones is IMMEUBLE LE CLEMENCEAU 1, 205, AVENUE GEORGES CLEMENCEAU, NANTERRE, HAUTS-DE-SEINE, 92024
What is the Neurones website address?
The website address for Neurones is www.neurones.net
Which industry sector does Neurones operate in?
Neurones operates in the COMPUTER PROGRAMMING SERVICE sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
Huggy Bear Huggy Bear 3 minutes ago
Yeah, that a real stretch all right.
HMBL
demonsmith demonsmith 4 minutes ago
I think by wensday
TWOH
Truthfan Truthfan 4 minutes ago
“If CRL were so important for NWBO, why would kelly ganjei who is listed as co-inventor of the combo patent leave CRL for AmplifyBio along with his two high-caliber associates?”

All three personnel mentioned in your post are from Toucan Capital…..Ganjei, Yoon, and Khoury. I know you
NWBO
Hosai Hosai 4 minutes ago
Anavex post on wall street bets - https://www.reddit.com/r/wallstreetbets/comments/1htw4nu/avxl_alzheimers_stock_delivering_tendies/
AVXL
TheHound TheHound 4 minutes ago
IPIX is dead as well as its association w/ B and the laser boys as evidenced by its lack of reporting or communication with anyone.
IPIX
Konaploinks Konaploinks 4 minutes ago
The term “probably object framework” isn’t standard in quantum computing literature. However, if we interpret it as a framework designed to handle probabilistic objects or models, its integration with quantum computing, particularly in combinatorial optimization, presents both opportunities and chal
al44 al44 4 minutes ago
Wake up America, learn from England-

https://media.gettr.com/group6/getter/2025/01/05/15/8e6f6a6b-a0d9-4007-c30a-5e4b0e40c7f0/bc5970ddaa9d6164f55efe27c8a8210a_768x0.jpg
krab krab 5 minutes ago
At times you come out with the most stupidest remarks, that makes no sense !!!
FNMA
IB_ IB_ 5 minutes ago
You do not lower the price when you are selling all you are allowed to make !!!!!!!!!!!!!!!!!
That would be stupid ............

" If Adderall is getting more competitive, we may be lowering prices to maintain same market share which would decrease revs."

IB_
ELTP
3331 3331 5 minutes ago
GetSeriousOk Post #325074:
Friday, 12/22/2023 12:02:48 PM

Positives for BIEL:
1. It's a real company with a real product.
2. The company is not burning $$$ millions every quarter trying to get a product through the FDA wringer. T
BIEL
Zardiw Zardiw 6 minutes ago
#DDAmanda Video - $FCUV - Gain: +137% Video Analysis - #1 Stock Screener / Scanner

Questions/Support: 760 702-2009 - Hans@DDAmanda.com

https://www.youtube.com/watch?v=39M1FdrWh4g

Z
FCUV
sylvia07 sylvia07 6 minutes ago
I know naked shorts are in dbmm but I think it was the website it self I heard was fake, if shorts was not in it stock barber and other liars would not be working so hard to convince they are not.
DBMM
Value_Investor Value_Investor 7 minutes ago
Do you know where or from which brokerage firm I can buy PRCX shares now? I wish to Buy-Out the Entire float at $0.0001, instead of $0.000001!

Because buying its peer (FCCN) at its Record-High $41.3 = buying PRCX at $0.3!

https://www.stockscores.com/chart.asp?TickerSymb
PRCX
Zardiw Zardiw 7 minutes ago
Yeah, but it'll never happen........maybe he'll pardon Himself......lol...........

Z
StayHumble StayHumble 7 minutes ago
💹Ellwood Thompson’s Stores💹Accelerate Revenue $75M+ Annually 💹 https://www.healthiercmc.com/news/231002-ellwood-thompsons
Ellwood Thompson’s,- An Organic and Natural Health food and vitamin store located in Richmond, Virginia.✅


Ellwood Tho
HCWC
HGilS HGilS 7 minutes ago
I can see that happening
ELTP
cjstocksup cjstocksup 8 minutes ago
NEW: Two women arrested after a police officer suffered a brutal head injury while trying to stop one of the women from fleeing the scene.

The police officer was sent to the hospital for a head injury and remains in serious condition.

28-year-old Jamaysha Butler could b
MarauderWarlock33 MarauderWarlock33 8 minutes ago
Crash

NWBO changed the original comb trial partner BMY to Merck about 4 years ago at UCLA then LP made a comment about BP got nothing to offer but money. So what Merck offer that BMY couldn't or wouldn't - maybe manufacturing and distribution ? She also mentioned specifically combo d
BMY NWBO
bar1080 bar1080 8 minutes ago
Their auditor:

/s/ WithumSmith+Brown, PC
We have served as the Company's auditor since 2020.
East Brunswick, New Jersey
March 31, 2022
PCAOB ID Number 100"

"scientific nobel clinical trial" ????
rocket7878 rocket7878 9 minutes ago
Hope is probably accurate for most here with the same plan to get out. The only “communication”since coming back from caveat emptor in 2017 are the filings. Been nothing but speculation by any of us wondering why they’ve kept the quarterlies and annuals current since 2021. Unaudited of course, just
GEGP
jimr1717 jimr1717 10 minutes ago
The Hutchison Effect is said to be the cause of the bolts coming out of the Boeing plane’s door in flight.
It is a rumor that Boeing has ordered a full case of Ozone-Saver3000 © which would bring a little over 1 billion in revenue for SINT.
SINT
al44 al44 10 minutes ago
Democrats and DEI hires-

https://media.gettr.com/group7/getter/2025/01/05/14/f89d94a5-ca6c-27c0-48a9-13094c4a4307/709156718cd6ec7f8ac1d112c9ca27ce_768x0.jpg
cjstocksup cjstocksup 10 minutes ago
Remember all those foreign students who publicly celebrated when Hamas terrorists killed over 1,000 innocent people?

Our incredible incoming US Attorney General
@PamBondi
says they will soon be deported

Sorry but we don’t want people who celebrate terror
frenchbroad frenchbroad 12 minutes ago
Explain please for a Ipix investor or any one: "There’s every reason to believe IPIX no longer has any stake in BeaMed..."
You have every. It is a lot. Choose one.
"Actually with literally 50 years of pharma patent experience behind me, I can tell you categorically...." https://investo
IPIX

Your Recent History

LSE
0GX2
Neurones
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads